Ecology of West Nile virus in California exemplifies the One Health paradigm

2016 ◽  
Author(s):  
William K. Reisen
Keyword(s):  
2020 ◽  
Vol 39 (2) ◽  
pp. 40-47 ◽  
Author(s):  
Tatjana Vilibić-Čavlek ◽  
Dejan Vidanović ◽  
Ljubo Barbić ◽  
Pavle Jeličić ◽  
Sava Lazić ◽  
...  

West Nile virus (WNV) danas je jedan od najrasprostranjenijih arbovirusa. U posljednja se dva desetljeća WNV infekcije kontinuirano pojavljuju na području Europe u obliku manjih ili većih epidemija i epizootija. U ovom preglednom radu prikazujemo epidemiološke značajke WNV infekcija koje su dokazane na području Hrvatske i Srbije u kontekstu “Jednog zdravlja”. Prikazani rezultati potvrđuju značaj multidisciplinarne i regionalne suradnje u dijagnostici i praćenju ove (re-)emergentne virusne zoonoze.


2021 ◽  
Vol 12 ◽  
Author(s):  
Jennifer Stander ◽  
Aleyo Chabeda ◽  
Edward P. Rybicki ◽  
Ann E. Meyers

West Nile virus (WNV) is a globally disseminated Flavivirus that is associated with encephalitis outbreaks in humans and horses. The continuous global outbreaks of West Nile disease in the bird, human, and horse populations, with no preventative measures for humans, pose a major public health threat. The development of a vaccine that contributes to the “One Health” Initiative could be the answer to prevent the spread of the virus and control human and animal disease. The current commercially available veterinary vaccines are generally costly and most require high levels of biosafety for their manufacture. Consequently, we explored making a particulate vaccine candidate made transiently in plants as a more cost-effective and safer means of production. A WNV virus-like particle-display-based vaccine candidate was generated by the use of the SpyTag/SpyCatcher (ST/SC) conjugation system. The WNV envelope protein domain III (EDIII), which contains WNV-specific epitopes, was fused to and displayed on AP205 phage virus-like particles (VLPs) following the production of both separately in Nicotiana benthamiana. Co-purification of AP205 and EDIII genetically fused to ST and SC, respectively, resulted in the conjugated VLPs displaying EDIII with an average coupling efficiency of 51%. Subcutaneous immunisation of mice with 5 μg of purified AP205: EDIII VLPs elicited a potent IgG response to WNV EDIII. This study presents the potential plants being used as biofactories for making significant pharmaceutical products for the “One Health” Initiative and could be used to address the need for their local production in low- and middle-income countries (LMICs).


Pathogens ◽  
2020 ◽  
Vol 9 (7) ◽  
pp. 589 ◽  
Author(s):  
Gervais Habarugira ◽  
Willy W. Suen ◽  
Jody Hobson-Peters ◽  
Roy A. Hall ◽  
Helle Bielefeldt-Ohmann

West Nile virus (WNV) is an important zoonotic flavivirus responsible for mild fever to severe, lethal neuroinvasive disease in humans, horses, birds, and other wildlife species. Since its discovery, WNV has caused multiple human and animal disease outbreaks in all continents, except Antarctica. Infections are associated with economic losses, mainly due to the cost of treatment of infected patients, control programmes, and loss of animals and animal products. The pathogenesis of WNV has been extensively investigated in natural hosts as well as in several animal models, including rodents, lagomorphs, birds, and reptiles. However, most of the proposed pathogenesis hypotheses remain contentious, and much remains to be elucidated. At the same time, the unavailability of specific antiviral treatment or effective and safe vaccines contribute to the perpetuation of the disease and regular occurrence of outbreaks in both endemic and non-endemic areas. Moreover, globalisation and climate change are also important drivers of the emergence and re-emergence of the virus and disease. Here, we give an update of the pathobiology, epidemiology, diagnostics, control, and “One Health” implications of WNV infection and disease.


Author(s):  
Giusi Macaluso ◽  
Francesca Gucciardi ◽  
Annalisa Guercio ◽  
Valeria Blanda ◽  
Francesco La Russa ◽  
...  

2016 ◽  
Vol 53 ◽  
pp. 33
Author(s):  
G. Paternoster ◽  
S. Babo Martins ◽  
A. Mattivi ◽  
R. Cagarelli ◽  
P. Angelini ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Mariana Geffroy ◽  
Nonito Pagès ◽  
David Chavernac ◽  
Alexis Dereeper ◽  
Lydéric Aubert ◽  
...  

After spreading in the Americas, West Nile virus was detected in Guadeloupe (French West Indies) for the first time in 2002. Ever since, several organizations have conducted research, serological surveys, and surveillance activities to detect the virus in horses, birds, mosquitoes, and humans. Organizations often carried them out independently, leading to knowledge gaps within the current virus' situation. Nearly 20 years after the first evidence of West Nile virus in the archipelago, it has not yet been isolated, its impact on human and animal populations is unknown, and its local epidemiological cycle is still poorly understood. Within the framework of a pilot project started in Guadeloupe in 2019, West Nile virus was chosen as a federative model to apply the “One Health” approach for zoonotic epidemiological surveillance and shift from a sectorial to an integrated surveillance system. Human, animal, and environmental health actors involved in both research and surveillance were considered. Semi-directed interviews and a Social Network Analysis were carried out to learn about the surveillance network structure and actors, analyze information flows, and identify communication challenges. An information system was developed to fill major gaps: users' needs and main functionalities were defined through a participatory process where actors also tested and validated the tool. Additionally, all actors shared their data, which were digitized, cataloged, and centralized, to be analyzed later. An R Shiny server was integrated into the information system, allowing an accessible and dynamic display of data showcasing all of the partners' information. Finally, a series of virtual workshops were organized among actors to discuss preliminary results and plan the next steps to improve West Nile Virus and vector-borne or emerging zoonosis surveillance. The actors are willing to build a more resilient and cooperative network in Guadeloupe with improved relevance, efficiency, and effectiveness of their work.


2019 ◽  
Vol 66 (5) ◽  
pp. 1946-1957 ◽  
Author(s):  
Tatjana Vilibic‐Cavlek ◽  
Vladimir Savic ◽  
Dario Sabadi ◽  
Ljiljana Peric ◽  
Ljubo Barbic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document